Bajahzer Mohammed F, Rosqvist Fredrik, Fridén Michael, Iggman David, Pingel Ronnie, Marklund Matti, Risérus Ulf
Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden; Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
J Nutr. 2023 Mar;153(3):683-690. doi: 10.1016/j.tjnut.2023.01.005. Epub 2023 Jan 13.
It is unclear whether moderate differences in dietary carbohydrate quantity and quality influence plasma FAs in the lipogenic pathway in healthy adults.
We investigated the effects of different carbohydrate quantities and quality on plasma palmitate concentrations (primary outcome) and other saturated and MUFAs in the lipogenic pathway.
Twenty healthy participants were randomly assigned, and 18 (50% women; age: 22-72 y; BMI: 18.2-32.7 kg/m and BMI was measured in kg/m) started the cross-over intervention. During each 3-wk period (separated by a 1-wk washout period), 3 diets were consumed (all foods provided) in random order: low-carbohydrate (LC) (38% energy (E) carbohydrates, 25-35 g fiber/d, 0% E added sugars); high-carbohydrate/high-fiber (HCF) (53% E carbohydrates, 25-35 g fiber/d, 0% E added sugars); and high-carbohydrate/high-sugar (HCS) (53% E carbohydrates, 19-21 g fiber/d, 15% E added sugars). Individual FAs were measured proportionally to total FAs by GC in plasma cholesteryl esters, phospholipids, and TGs. False discovery rate-adjusted repeated measures ANOVA [ANOVA-false discovery rate (FDR)] was used to compare outcomes.
The self-reported intakes of carbohydrates and added- and free sugars were; 30.6% E and 7.4% E in LC, 41.4% E and 6.9% E in HCF, and 45.7% E and 10.3% in HCS. Plasma palmitate did not differ between the diet periods (ANOVA FDR P > 0.43, n = 18). After HCS, myristate concentrations in cholesterol esters and phospholipids were ≥19% higher than LC and ≥22% higher than HCF (P = 0.005). After LC, palmitoleate in TG was 6% lower compared with HCF and 7% compared with HCS (P = 0.041). Body weight differed (≤0.75 kg) between diets before FDR correction.
Different carbohydrate quantity and quality do not influence plasma palmitate concentrations after 3 wk in healthy Swedish adults, whereas myristate increased after the moderately higher intake of carbohydrate/high-sugar, but not carbohydrate/high-fiber. Whether plasma myristate is more responsive than palmitate to differences in carbohydrate intake requires further study, especially considering that participants deviated from the planned dietary targets. J Nutr 20XX;xx:xx-xx. This trial was registered at clinicaltrials.gov as NCT03295448.
目前尚不清楚饮食中碳水化合物数量和质量的适度差异是否会影响健康成年人脂肪生成途径中的血浆脂肪酸。
我们研究了不同碳水化合物数量和质量对血浆棕榈酸浓度(主要结果)以及脂肪生成途径中其他饱和脂肪酸和单不饱和脂肪酸的影响。
20名健康参与者被随机分配,其中18人(50%为女性;年龄:22 - 72岁;体重指数:18.2 - 32.7 kg/m²,体重指数以kg/m²为单位测量)开始交叉干预。在每个3周期间(间隔1周的洗脱期),随机顺序食用3种饮食(提供所有食物):低碳水化合物(LC)(38%能量(E)来自碳水化合物,25 - 35 g纤维/天,0% E来自添加糖);高碳水化合物/高纤维(HCF)(53% E来自碳水化合物,25 - 35 g纤维/天,0% E来自添加糖);高碳水化合物/高糖(HCS)(53% E来自碳水化合物,19 - 21 g纤维/天,15% E来自添加糖)。通过气相色谱法按总脂肪酸的比例测量血浆胆固醇酯、磷脂和甘油三酯中的单个脂肪酸。采用错误发现率调整的重复测量方差分析[方差分析 - 错误发现率(FDR)]来比较结果。
自我报告的碳水化合物、添加糖和游离糖的摄入量分别为:LC组中为30.6% E和7.4% E,HCF组中为41.4% E和6.9% E,HCS组中为45.7% E和10.3% E。各饮食期之间血浆棕榈酸无差异(方差分析FDR P > 0.43,n = 18)。食用HCS后,胆固醇酯和磷脂中的肉豆蔻酸浓度比LC组高≥19%,比HCF组高≥22%(P = 0.005)。食用LC后,甘油三酯中的棕榈油酸比HCF组低6%,比HCS组低7%(P = 0.041)。在进行FDR校正之前,不同饮食之间体重存在差异(≤0.75 kg)。
在健康的瑞典成年人中,不同的碳水化合物数量和质量在3周后不会影响血浆棕榈酸浓度,而在适度较高的碳水化合物/高糖摄入后肉豆蔻酸增加,但碳水化合物/高纤维摄入后未增加。血浆肉豆蔻酸对碳水化合物摄入量差异的反应是否比棕榈酸更敏感需要进一步研究,尤其是考虑到参与者偏离了计划的饮食目标。《营养学杂志》20XX年;xx:xx - xx。该试验在clinicaltrials.gov上注册为NCT03295448。